Therapeutic Performance Evaluation of (213)Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([(213)Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology

Since NGR-tripeptides (asparagine-glycine-arginine) selectively target neoangiogenesis-associated Aminopeptidase N (APN/CD13) on cancer cells, we aimed to evaluate the in vivo tumour targeting capability of radiolabelled, NGR-containing, ANP/CD13-selective [(213)Bi]Bi-DOTAGA-cKNGRE in CD13pos. HT108...

Descripción completa

Detalles Bibliográficos
Autores principales: Képes, Zita, Arató, Viktória, Szabó, Judit P., Gyuricza, Barbara, Szücs, Dániel, Hajdu, István, Fekete, Anikó, Bruchertseifer, Frank, Szikra, Dezső, Trencsényi, György
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968005/
https://www.ncbi.nlm.nih.gov/pubmed/36839813
http://dx.doi.org/10.3390/pharmaceutics15020491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968005/
https://www.ncbi.nlm.nih.gov/pubmed/36839813
http://dx.doi.org/10.3390/pharmaceutics15020491

Ejemplares similares